Alfred Mann (Mannkind founder, largest stock holder and CEO)
It is hard to imagine one of the world’s richest men, Alfred Mann, growing up poor. This entrepreneur’s first business consisted of selling magazines and lemonade in Portland, Oregon during the Great Depression. He group up in a Jewish household with his mother father and brother, Robert Mann who went on to become a violinist. Mann attended the University of California at Los Angeles earning his B.S. and M.S. in physics, and post graduation, he founded and sold aerospace companies Spectrolab, Heliotek in the 1960s. The money he earned helped him to invest further in some of the world’s most innovative biomed firms, including Minimed, a company responsible for revolutionary easy-to-use insulin pumps.
Mann has been using his self-made fortune to create MannKind Corporation, a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and cancer. Interested in the future of diabetes care, Mannkind has invested $460 million into ultra fast-acting and inhaled insulin, despite the products being years away from approval. In June 2014 the U.S. Food and Drug Administration approved Mannkind Corporation’s application for Afrezza, an inhalable insulin to treat diabetes.
He is currently involved in a number of businesses. Mann is the founder and Chairman of Second Sight, the founder and Chairman of Bioness, Chairman of the Board of Quallion, LLC, and Stellar Microelectronics. In addition, Mann also chiars the Southern California Biomedical Council, which promotes the growth of life science in the Los Angeles area.
Mann is also well known for his philanthropic contributions. The Alfred Mann Foundation is dedicated to finding solutions for those suffering from debilitating medical impairments. In addition, the Alfred Mann Institutes have established biotech research labs funded to revolutionize medical devices.
Mann, who resides in Los Angeles, California, is married to Claude Mann and has seven children.
Nate Pile is the top-performing editor behind Nate’s Notes, an investment newsletter published for individual investors since 1995. Mr. Pile’s stock recommendations are independently tracked and ranked by The Hulbert Financial Digest.
According to Hulbert, Nate’s Notes has been ranked among the “Top 5 for real returns” numerous times over the years, periodically holding the prestigious #1 position for one-, three-, five-, ten-, and fifteen-year returns at various points in time.
Not on the list?
We forgot a high-profile bull? Drop us an email at: email@example.com